IVF is the process. The strategy is deciding how to use it.
IVF brings stimulation, egg retrieval, fertilization, embryo development and transfer into one connected treatment, and the quality of the experience depends on who interprets each stage and how the next decision is made. Dr. Aldape personally defines the strategy, reviews response and remains involved from the first plan through embryo and transfer decisions.
Strategy & preparation
Before treatment begins, Dr. Aldape reviews your fertility history, ovarian reserve, previous treatments and personal goals to define a strategy suited to your situation, not a fixed protocol. This includes identifying which parts of preparation—records review, selected testing and initial planning—can take place remotely before any travel is required.
Ovarian stimulation
Medication and close monitoring are used to recruit the follicular cohort that is available for that cycle, with dose and timing adjusted as your body responds. Response is interpreted throughout stimulation rather than assumed in advance, since ovarian reserve and prior treatment history shape what a reasonable outcome looks like.
Egg retrieval
Oocytes are retrieved once monitoring shows the follicles have reached the clinically appropriate stage, with the exact timing guided by hormone levels and the response to the trigger medication. This step marks the transition from ovarian stimulation to laboratory work, where fertilization and embryo development begin.
ICSI & embryo development
In Dr. Aldape's practice, ICSI is the routine fertilization approach, since it allows a single sperm to be introduced directly into each mature oocyte under laboratory conditions. Embryos are then observed through defined developmental milestones, from fertilization check through cleavage and blastocyst formation, so that each stage informs the next decision.
Embryo strategy & transfer
Culture duration, genetic testing when relevant, vitrification and transfer timing are considered as connected decisions rather than isolated steps, because each choice affects what the next one can achieve. The goal is a plan that reflects embryo development and the patient's history, not a single default sequence applied to every case.
One clinical narrative
The same physician who reviews your baseline history also interprets stimulation response, laboratory results and transfer planning, so no part of the story is lost between visits or providers. This continuity makes it possible to explain why a decision was made, not only what the decision was.
Individual decisions
Protocol, dose, trigger timing, fertilization approach and embryo strategy are considered together in the context of your age, ovarian reserve and treatment history, rather than applied as a fixed sequence. What works for one patient's biology and goals may not be the right plan for another.
Clear limits
IVF remains biological medicine, and no clinic can guarantee oocyte yield, blastocyst development, chromosomally normal embryos, implantation or live birth. Honest communication about these limits, alongside what the treatment can realistically offer, is part of how the strategy is explained at every stage.
International continuity
Remote preparation and travel are coordinated around the medicine rather than the other way around, so that stimulation, monitoring and retrieval happen at the clinically appropriate time. Follow-up after procedures continues with the same physician, keeping results and next steps connected to the plan that was already in place.
